Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1740043 | 1.00 | GCK (0.46) | GCKP2RX7 | |
| SCHEMBL3008569 | 0.98 | GCK (0.48) | GCK | |
| SCHEMBL1741312 | 0.97 | GCK (0.47) | GCK | |
| SCHEMBL1741313 | 0.97 | GCK (0.47) | GCK | |
| SCHEMBL3015004 | 0.91 | GCK (0.40) | GCKP2RX7 | |
| SCHEMBL3015006 | 0.91 | GCK (0.40) | GCKP2RX7 | |
| SCHEMBL3702379 | 0.86 | GCK (0.46) | GCK | |
| SCHEMBL3017123 | 0.84 | GCK (0.48) | GCK | |
| SCHEMBL3017083 | 0.84 | GCK (0.48) | GCK | |
| SCHEMBL1741636 | 0.81 | ALDH1A1 (0.34) | GCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8071606-B2 | Substituted pyrazinone amides useful for activation of glucokinase | PFIZER INC. (US) | 2011-12-06 | — | — | US | disclosed |
| US-8071606-B2 | Substituted pyrazinone amides useful for activation of glucokinase | PFIZER INC. (US) | 2011-12-06 | — | — | US | disclosed |
| US-8071606-B2 | Substituted pyrazinone amides useful for activation of glucokinase | PFIZER INC. (US) | 2011-12-06 | — | — | US | disclosed |
| EP-2389374-A1 | SUBSTITUTED PYRAZINONE AMIDES | Pfizer Inc. (US) | 2011-11-30 | — | — | EP | disclosed |
| US-20110254560-A1 | Electrical Systems and Battery Assemblies | KDT ACL INVESTMENTS, LLC | 2011-10-20 | — | — | US | disclosed |
| US-20100184777-A1 | Substituted Pyrazinone Amides | PFIZER INC | 2010-07-22 | — | — | US | disclosed |
| US-20100184777-A1 | Substituted Pyrazinone Amides | PFIZER INC | 2010-07-22 | — | — | US | disclosed |
| US-20100184777-A1 | Substituted Pyrazinone Amides | PFIZER INC | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184777-A1 | Substituted Pyrazinone Amides | GCK, GCKR, PDK2 | GCK 1/4885P2RX7 526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.